Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus

被引:33
作者
Lu, T
Zhao, XL
Li, XY
Hansen, G
Blondeau, J
Drlica, K
机构
[1] Publ Hlth Res Inst, Newark, NJ 07103 USA
[2] St Pauls Hosp Grey Nuns, Dept Clin Microbiol, Saskatoon, SK, Canada
[3] Saskatoon & Dist Hlth, Dept Clin Microbiol, Saskatoon, SK, Canada
[4] Royal Univ Hosp, Dept Pathol, Saskatoon, SK S7N 0W8, Canada
[5] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada
关键词
erythromycin; moxifloxacin; penicillin; tetracycline; chloramphenicol;
D O I
10.1093/jac/dkg268
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The effect of antimicrobial concentration on colony-forming ability of resistant mutant subpopulations of Mycobacterium smegmatis and Staphylococcus aureus was measured for chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline. The relationship between drug concentration and the recovery of mutant colonies was distinct for each bacterium-antimicrobial combination; however, in each case application of large numbers of cells to drug-containing agar plates revealed a progressive reduction in mutant recovery as antimicrobial concentration increased. The minimal concentration that allowed no mutant recovery from more than 10(10) input cells was measured to estimate the minimum inhibitory concentration (MIC) of the least susceptible, single-step mutant subpopulation, a parameter also called the mutant prevention concentration (MPC). These data expand the number of antimicrobial-bacterial combinations for which a mutant selection window can be measured.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 19 条
[1]   Increasing antimicrobial resistance in STDs and the need for surveillance:: Neisseria gonorrhoeae as a model [J].
Bal, Ç .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 24 (04) :447-453
[2]   ANTIMICROBIAL RESISTANCE OF SHIGELLA ISOLATES IN BANGLADESH, 1983-1990 - INCREASING FREQUENCY OF STRAINS MULTIPLY RESISTANT TO AMPICILLIN, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND NALIDIXIC-ACID [J].
BENNISH, ML ;
SALAM, MA ;
HOSSAIN, MA ;
MYAUX, J ;
KHAN, EH ;
CHAKRABORTY, J ;
HENRY, F ;
RONSMANS, C .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (05) :1055-1060
[3]   Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae [J].
Blondeau, JM ;
Zhao, XL ;
Hansen, G ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :433-438
[4]   Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus [J].
Dong, YZ ;
Zhao, XL ;
Domagala, J ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1756-1758
[5]   Mutant prevention concentration as a measure of antibiotic potency:: Studies with clinical isolates of Mycobacterium tuberculosis [J].
Dong, YZ ;
Zhao, XL ;
Kreiswirth, BN ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2581-2584
[6]   The mutant selection window and antimicrobial resistance [J].
Drlica, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :11-17
[7]   In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus [J].
Firsov, AA ;
Vostrov, SN ;
Lubenko, IY ;
Drlica, K ;
Portnoy, YA ;
Zinner, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1604-1613
[8]   Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance [J].
Gallardo, F ;
Ruiz, J ;
Marco, F ;
Towner, KJ ;
Vila, J .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (04) :367-374
[9]  
Glupczynski Y, 1998, ACTA GASTRO-ENT BELG, V61, P357
[10]  
Gorwitz Rachel J., 1993, Morbidity and Mortality Weekly Report, V42, P29